Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b7dc2a484577f19f86e2022eca356a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45570f8f0e9c62e698dff88c4ca1f46a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af00fdd02e34a80caaf6e594e7cc27e2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16234 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-215 |
filingDate |
2009-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dc038daad92ba6833f33f6e11eab000 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d91f7bed5e7130093563f3b3d85e902f |
publicationDate |
2010-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2010044921-A2 |
titleOfInvention |
Intranasal administration of receptor-binding ligands or genes encoding such ligands as a therapeutic regimen for mitigating infections caused by respiratory pathogens |
abstract |
The present invention relates to a receptor-binding ligand either administered intranasally or expressed following intranasal administration from a recombinant vector that expresses at least one therapeutic ligand which binds to a receptor necessary for infection by a respiratory pathogen. The receptor-binding ligand in the respiratory tract not only confers rapid protection as a therapeutic drug but also elicits long-term protective immunity as a vaccine against a respiratory pathogen. This regimen is not compromised by the emergence of drug resistance because the receptor for any pathogen can be blocked by the pathogen's own receptor-binding ligand. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3953457-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10786568-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022155476-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11535665-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3699286-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11578341-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012145572-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022077593-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021254476-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021211629-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021224946-A1 |
priorityDate |
2008-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |